Home >Research Technology Management>Technology for Licensing
Institut Pasteur Korea has successfully established technology platforms for image analysis and target identification. This unique quality enabled us to discover new treatments for disease.
Anti-infective compounds (Tuberculosis APPN)
Genome wide visual identification of human co-factors of HIV-1 infection
Method and apparatus for imaging of features on a substrate
Anti-infective compounds (Tuberculosis IPA)
Compounds for treating viral infections (Hepatitis C Virus)
Anti-infective compounds (Tuberculosis)
Compounds for treatment of inflammatory diseases, cancer, stroke, and Alzheimer's disease